Immunomedics (IMMU) Commences $275 Million Offering of Common Stock

June 11, 2018 4:13 PM

Immunomedics, Inc. (NASDAQ: IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that it has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found